Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	304.97	292.09	415.52	546.09	246.55	398.7
Cash & Short-Term Investments	304.97	292.09	415.52	546.09	246.55	398.7
Cash Growth	-5.58%	-29.70%	-23.91%	121.50%	-38.16%	12.55%
Accounts Receivable	196.02	147.66	117.29	98.13	94.5	52.04
Other Receivables	-	-	23.74	20.25	9.76	11.88
Total Trade Receivables	196.02	147.66	141.04	118.37	104.26	63.91
Inventory	227.87	248.46	227.41	141.6	106.57	77.59
Other Current Assets	-	-	29.11	20.34	10.14	7.34
Total Current Assets	728.86	688.21	813.08	826.41	467.51	547.53
Net Property, Plant & Equipment	218.28	213.88	149.04	97.55	47.58	26.3
Other Intangible Assets	927.14	840.29	724.8	628.97	553	465.21
Goodwill	633.46	610.06	682.48	591.39	625.32	460.23
Other Long-Term Assets	19.12	21.67	33.35	51.3	39.68	43.33
Total Assets	2,527	2,374	2,403	2,196	1,733	1,543
Accounts Payable	177.14	107.82	39.45	36.05	38.47	21.45
Accrued Expenses	-	-	98.54	72.63	55.82	49.97
Current Portion of Long-Term Debt	11.7	11.56	10.92	10.27	5.55	4.2
Other Current Liabilities	-	-	28.6	15.53	35.06	28.91
Total Current Liabilities	188.83	119.38	177.51	134.49	134.9	104.52
Long-Term Debt	109.92	113.17	23.13	21.17	4.46	1.52
Other Long-Term Liabilities	27.89	28.11	45.33	94.91	163.6	151.11
Total Long-Term Liabilities	137.81	141.28	68.46	116.08	168.05	152.63
Total Liabilities	326.64	260.65	245.97	250.57	302.95	257.15
Common Stock	-	-	0.81	0.81	0.76	0.75
Additional Paid-in Capital	-	-	1,772	1,764	1,314	1,253
Accumulated Other Comprehensive Income	-	-	92.19	60.89	87.78	22.09
Retained Earnings	-	-	291.76	119.57	27.75	9.28
Shareholders' Equity	2,200	2,113	2,157	1,945	1,430	1,285
Total Liabilities & Equity	2,527	2,374	2,403	2,196	1,733	1,543
Total Debt	121.62	124.72	34.04	31.44	10.01	5.72
Net Cash (Debt)	183.35	167.37	381.48	514.65	236.54	392.98
Net Cash Growth	-13.59%	-56.13%	-25.88%	117.58%	-39.81%	13.24%
Net Cash Per Share	5.81	5.30	12.05	17.19	8.01	13.58
Book Value	2,200	2,113	2,157	1,945	1,430	1,285
Book Value Per Share	69.74	66.97	68.14	64.98	48.44	44.42
Tangible Book Value	639.61	663.11	749.5	724.69	251.82	360.01
Tangible Book Value Per Share	20.27	21.01	23.68	24.21	8.53	12.44